MNKD August 23rd Options Begin Trading
|
|
Mannkind
|
Jul 18, 2013 11:33AM
|
MannKind Corporation to Present at JMP Securities 7th Annual Healthcare Conferen
|
|
Mannkind
|
Jul 05, 2012 05:35PM
|
Re: Exubera's ghost
|
|
Mannkind
|
Apr 04, 2013 05:50PM
|
Merck and Abide to develop diabetes drugs in deal potentially worth $430M
|
|
Mannkind
|
May 03, 2013 10:28AM
|
Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
|
Mannkind
|
Mar 27, 2013 01:22PM
|
The Case Against Afrezza, and Mannkind
|
|
Mannkind
|
Apr 11, 2013 04:53PM
|
Re: We get a mention...
|
|
Mannkind
|
Apr 12, 2012 12:46PM
|
Re: Newbie to Options
|
|
Mannkind
|
Jul 19, 2013 04:43PM
|
Re: The fools
|
|
Mannkind
|
Jun 21, 2012 12:30PM
|
Baba,
|
|
Mannkind
|
Oct 16, 2012 09:55AM
|
Zacks Reaffirms Neutral Rating on MannKind (MNKD)
|
|
Mannkind
|
Oct 17, 2012 03:56PM
|
Re: How about a few guesses as to the terms of the offering?
|
|
Mannkind
|
Oct 18, 2012 10:25AM
|
Re: MannKind Rents Out a Drug Program
|
|
Mannkind
|
May 02, 2012 12:48PM
|
Re: CC Notes
|
|
Mannkind
|
Feb 11, 2013 08:33PM
|
Re: Jan 14, 7 Calls
|
|
Mannkind
|
Mar 28, 2012 04:44PM
|
3 Investment Ideas for Biotech Investors
|
|
Mannkind
|
Apr 30, 2013 11:29PM
|
Form S-3ASR
|
|
Mannkind
|
Jul 19, 2013 04:44PM
|
Why No One Cares About MannKind's Earnings
|
|
Mannkind
|
Feb 12, 2013 01:04PM
|
8-K
|
|
Mannkind
|
Oct 19, 2012 06:15PM
|
Re: ASM Questions
|
|
Mannkind
|
May 15, 2012 10:03PM
|